一、分论坛介绍

2022年上海交通大学医学院国际青年学者云论坛分论坛——基础医学分论坛，由上海交通大学医学院主办，上海交通大学基础医学院承办，论坛根据现有的学科优势以及生命医学发展的趋势，聚焦国际学术前沿，组织设立“代谢调控”、“精准药学”、“免疫生物学与临床免疫研究新进展”、“脑与多器官互作”、“细胞命运决定”、“肿瘤分型与治疗”和“生殖与遗传·干细胞与发育”七个学科方向（具体详见论坛各系学科简介）。通过学术交流与人才洽谈等形式，汇聚海内外优秀青年人才，共创基础医学美好未来。

二、承办单位介绍

上海交通大学基础医学院的前身为创建于1955年8月的上海第二医学院基础医学部，1989年5月成立上海第二医科大学基础医学院。2005年，上海交通大学与上海第二医科大学强强联合，基础医学院更名为上海交通大学基础医学院。基础医学院是上海交通大学医学院基础医学教学、科研和人才培养的重要基地。

学院现有国家“双一流”建设学科2个（基础医学、药学）、国家重点学科1个（病理学与病理生理学）、教育部“211工程”重点建设学科4个（医学分子细胞生物学、医学免疫学、病理学与病理生理学、遗传发育与生殖生物学）。生物学与生物化学、分子生物学与遗传学、药理学与毒理学、神经科学与行为学、免疫学、微生物学进入ESI全球前1%，其中生物学与生物化学、分子生物学与遗传学、药理学与毒理学进入前1‰。（更多详情）。

三、论坛主席介绍

论坛主席：程金科

程金科，上海交通大学医学院特聘教授，博士生导师，现任基础医学院院长，上海市肿瘤微环境与炎症重点实验室主任。中国生物化学与分子生物学会医学生物化学与分子生物学分会副主任委员，上海市生物化学与分子生物学学会理事长，上海市细胞生物学学会副理事长。主要从事蛋白质的SUMO修饰的基础与疾病方面的研究, 包括由SENP介导的去SUMO修饰过程和对细胞信号转导的调控机制，以及它们在发育与疾病过程中的作用与意义。在Cell, Nature Communications, Molecular Cell, Cancer Research, Cell Report, Oncogene等杂志发表研究论文50多篇。国家重点研发计划项目首席科学家，已获得多项国家自然科学基金重点项目和上海市科委等基金资助。

论坛主席：苏冰

苏冰，上海交通大学医学院上海市免疫学研究所所长、免疫学与微生物学系主任，博士生导师；上海交通大学医学院-耶鲁免疫代谢研究院主任、上海交通大学王宽诚讲席教授、耶鲁大学医学院免疫生物学系客座教授、中南大学湘雅医院客座教授博士生导师、国家重点研发计划首席科学家、科技部国际科技合作基地主任、国家高层次人才计划专家, 以及上海市高层次人才计划专家。

苏冰教授长期致力于细胞信号转导研究，尤其是MAPK和mTOR信号通路的调控机制及在免疫反应中的作用，取得了一系列原创性科学发现，在Nature、Cell、Nature Genetics、Nature Immunology、Immunity、Molecular Cell及EMBO J等杂志上发表论文110余篇，他引超过15000次。已获得科技部重点研发计划（首席科学家）、国家自然科学基金重大研究计划、重点项目、面上项目、及上海市科委、卫计委等多项资助。此外，苏冰教授曾担任美国华人生物学家协会秘书长和理事会委员，现任《现代免疫学》杂志主编，Journal of Molecular Cell Biology和Current Research in Immunology杂志副主编，《中国科学》、Immunology and Cell Biology、Cellular Immunology等杂志编委，是国家自然基金委重点/面上项目及美国NIH、AHA等多个学科组的专业委员和项目评审专家。

四、分论坛议程（待定）

五、联系方式

郑老师，电话：+86-21-63846590-776208   E-mail：rctq@shsmu.edu.cn

范老师，电话：+86-21-63846590-776280   E-mail：rctq@shsmu.edu.cn

徐老师，电话：+86-21-63846590-776267   E-mail：rctq@shsmu.edu.cn

Sub-forum of Basic Medical Sciences

1. Forum Introduction

Sponsored by Shanghai Jiao Tong University School of Medicine, the 2022 Forum of Distinguished Young Scholar on Basic Medical Sciences is organized by the College of Basic Medical Sciences.  This forum will focus on the international academic frontier and establish 7 discipline directions based on the existing discipline advantages and development trend of life science (Please check the introduction of each department), including Metabolism regulation, Precision pharmacology, Recent advances in basic and clinical immunology research, Peripheral tissue-brain interactions, Cell death and differentiation, Tumor classification and treatment, Reproduction and genetics & stem cell and developmental biology.  Through academic exchanges and talent negotiations, we will gather outstanding young talents at home and abroad to create a better future for basic medical sciences.

2. Organizer Introduction

The former College of Basic Medical Sciences was the Basic Medical Department of Shanghai Second Medical University established in August 1955, then changed to the College of Basic Medical Sciences.  In 2005, the college reformed to Shanghai Jiao Tong University College of Basic Medical Sciences through the powerful combination of Shanghai Jiao Tong University and Shanghai Second Medical University.  It provides the foundation for medical teaching, scientific research and talent cultivation for Shanghai Jiao Tong University School of Medicine.

The college has 2 national “First-class” disciplines in Basic medical sciences and Pharmacy, 1 national key discipline in Pathology and pathophysiology, 4 key construction disciplines of “211 Project” by Ministry of Education in Medical molecular cell biology, Medical immunology, Pathology and pathophysiology, Genetic development and reproductive biology.  There are 6 basic medical sciences disciplines of the college were selected as the top 1% of ESI global ranking.  Please check the college website for more details.

https://www.shsmu.edu.cn/cbms/info/1009/3180.htm

3. President Introduction

Cheng Jinke, Distinguished Professor of Shanghai Jiao Tong University School of Medicine, Doctoral Supervisor, Dean of College of Basic Medical Sciences, Chair of Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Vice chairman of CSBMB, Director of SSBMB, Deputy Director of SSCB.  He focuses on the basic and disease research of protein SUMO modification, including SENP-mediated deSUMOylation and the regulation mechanism of cell signal transduction, and their role and significance in the development and disease process.  Professor Cheng has published more than 50 articles on Cell, Nature Communications, Molecular Cell, Cancer Research, Cell Report, Oncogene, etc. and has been supported a number of key projects by NSFC, National Key R&D Program (Chief Scientist), Science and Technology Commission of Shanghai Municipality, etc..

Dr. Bing Su is the Director of Shanghai Institute of Immunology and Chair of Department of Immunology and Microbiology at Shanghai Jiao Tong University School of Medicine.  He is also the Director of Shanghai Jiao Tong University School of Medicine-Yale University Institute for Immune Metabolism (SYIIM).  Dr. Su is also an Adjunct Professor at Department of Immunobiology at Yale University School of Medicine, Central South University Xiang-Ya Hospital, and Shanghai University of Chinese Medicine.  In addition, Dr. Su also holds a KC Wong Chair Professorship at Shanghai Jiao Tong University, and is the Director of International Science & Technology Cooperation Base (ISTCB) of Minister of Science & Technology (MOST) at Shanghai Jiao Tong University School of Medicine.

Dr. Su’s research focuses on the intracellular signal transduction pathways controlled by the mammalian target of rapamycin (mTOR) and the mitogen activated protein kinases (MAPKs).  He studies the roles of these intracellular signaling cascades in immune system and in vascular function.  Dr. Su has published over 110 peer-reviewed papers, many of which are in high-impact journals such as Nature, Cell, Nature Genetics, Nature Immunology, Immunity, Molecular Cell, EMBO J, etc., with over 15000 citations.  His research has been supported by grants awarded by Ministry of National Science and Technology (Chief Scientist), National Natural Science Foundation of China (NSFC) (Key and general grants) and Shanghai Science and Technology Commission. Dr. Su is a life-member of Chinese Biological Investigator Society and Society of Chinese Bioscientists in America (SCBA).  He served on many review committees including NIH Study Sections and the Review Committee for the Key Programs of NSFC, etc.  He is also the editor-in-chief of Current Immunology, and the associate editor of Journal of Molecular Cell Biology and Current Research in Immunology.

4. Forum Agenda（TBD）

5. CONTACT US

Ms. Zheng, Tel: +86-21-63846590-776208 E-mail: rctq@shsmu.edu.cn

Ms. Fan,  Tel: +86-21-63846590-776280 E-mail: rctq@shsmu.edu.cn

Mr. Xu,   Tel: +86-21-63846590-776267 E-mail: rctq@shsmu.edu.cn